Enabling Affordable Biologics Through Advanced Process Optimization: A Manufacturing Case Study

Affordability remains a key challenge for biologic medicines, particularly for mature products under increasing cost and access pressure. Beyond innovation at the molecule level, manufacturing efficiency and robustness are critical enablers of sustainable patient access. This presentation demonstrates how systematic process optimization can significantly improve productivity, execution reliability, and cost-efficiency of biologic drug substance manufacturing. A real-life case study shows how an underperforming manufacturing process was transformed into a robust and scalable solution through structured postvalidation improvement. Targeted optimization and selective revalidation of critical process steps resulted in measurable gains in yield, consistency, and operational performance without major infrastructure changes. The case highlights the value of deep process understanding, data-driven decisions, and disciplined GMP execution. Ultimately, it illustrates how advanced manufacturing capabilities directly support cost reduction and supply sustainability, key drivers of biologics affordability, as well as showcases Rezon Bio’s strength in continuously improving and future-proofing biologic manufacturing processes